Indian pharmaceutical company Natco Pharma Ltd. has announced the launch of generic Ozempic copies, priced at just ₹1,290 ($14) per month, in response to Novo Nordisk’s patent expiry. This move aims to make weight-loss and diabetes medication more affordable for the country’s third-largest overweight population.
Source: https://www.bloomberg.com/news/articles/2026-03-20/ozempic-copies-to-cost-14-in-india-as-generic-glp-1-era-starts